It treats dosage and titration pace as its own factor, saying slower titration typically allows metabolic adaptation while rapid escalation may increase transient fatigue during weeks two to four
Hjorthj C, Compton W, Starzer M, Nordholm D, Einstein E, Erlangsen A, et al
This holistic approach recognizes obesity as a root cause rather than a consequence, aiming to improve overall patient health and simultaneously reduce the burden of multiple chronic diseases. However, Ortiz believes it is too early to take an obesity first approach for autoimmune disease
Because NHIS does not include information on all weight-related conditionssuch as obstructive sleep apnea, peripheral arterial disease, and aortic atherosclerosisthe number and share of the private and ESI markets indicated for GLP-1 drugs are potentially underestimated among those who are overweight